CTD Inc. Information

View Top Employees from CTD Inc.

CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company's Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical trials (Clinical Trials.gov NCT02939547, NCT02912793 and NCT03893071). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development.

Website	http://www.cyclodex.com
Revenue	$1 million
Employees	15 (9 on RocketReach)
Founded	2000
Address	PO Box 1180, Alachua, Florida 32616, US
Phone	+1 386-418-8060
Industry	Chemicals, Petrochemicals, Glass & Gases, Manufacturing
Web Rank	24 Million
Keywords	Clinical Stage Biotechnology, Novel Drug Delivery Systems, Therapeutic Drug Delivery, New Drug Delivery, Drug Product Development, Targeted Drug Delivery, Orphan Drug Development, Pharmaceutical Development, Controlled Release Formulations, Advanced Drug Delivery, Pharmaceutical Technology, Biopharmaceutical Manufacturing, Biotechnology Research
Competitors	Thermo Fisher Scientific, Merck Group, Agilent Technologies, MilliporeSigma, PerkinElmer, Inc., Waters Corporation, Avantor, VWR, part of Avantor, Fisher Scientific, Scharlab, S.L. +35 more (view full list)
SIC	SIC Code 289 Companies, SIC Code 28 Companies
NAICS	NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3259 Companies, NAICS Code 325998 Companies, NAICS Code 32599 Companies